Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)
Piessevaux, H., Buyse, M., De Roock, W., Prenen, H., Schlichting, M., Van Cutsem, E., Tejpar, S.Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp011
Date:
August, 2009
File:
PDF, 246 KB
english, 2009